Skip to main content Accessibility help
×
Home

Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia

  • Zsuzsa Litvan (a1), Martin Bauer (a1), Siegfried Kasper (a1) and Richard Frey (a1)

Abstract

Information on efficacy and safety of electroconvulsive therapy in patients with dementia is sparse. The current case report describes a patient suffering from severe depression and dementia who received electroconvulsive therapy with S-ketamine anesthesia at our psychiatric intensive care unit for the treatment of her therapy-resistant catatonic stupor. The patient's condition improved remarkably through the treatment. By the end of 16 electroconvulsive therapy sessions, her catatonic symptoms remitted entirely, her affect was brighter and she performed markedly better at the cognitive testing.

Copyright

Corresponding author

Correspondence should be addressed to: Dr Zsuzsa Litvan, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Waehringer Guertel 18–20 A-1090 Vienna, Austria. Phone: +431/40400-35470. Email: zsuzsa.litvan@meduniwien.ac.at.

References

Hide All
Bush, G., Fink, M., Petrides, G., Dowling, F. and Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93, 129136.
Diazgranados, N. et al. (2010). A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Archives of General Psychiatry, 67, 793802.
Kranaster, L., Kammerer-Ciernioch, J., Hoyer, C. and Sartorius, A. (2011). Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. European Archives of Psychiatry and Clinical Neuroscience, 261, 575582.
Krystal, A. D. et al. (2003). Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 2734.
Krystal, A. D. and Coffey, C. E. (1997). Neuropsychiatric considerations in the use of electroconvulsive therapy. The Journal of Neuropsychiatry and Clinical Neurosciences, 9, 283292.
Mathew, S. J. et al. (2012). Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs, 26, 189204.
Rao, V. and Lyketsos, C. G. (2000). The benefits and risks of ECT for patients with primary dementia who also suffer from depression. International Journal of Geriatric Psychiatry, 15, 729735.
Rosow, C. and Manberg, P. J. (2001). Bispectral index monitoring. Anesthesiology Clinics of North America, 19, 947966.
Sackeim, H. A. et al. (1993). Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. The New England Journal of Medicine, 328, 839846.
Winkler, D. et al. (2011). Intensive care in psychiatry. European Psychiatry: the Journal of the Association of European Psychiatrists, 26, 260264.
Zarate, C. A. et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63, 856864.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed